GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

It involves a buildup of fat in your liver, inflammation, and damage. Nonalcoholic steatohepatitis (NASH) is a more severe form of nonalcoholic fatty liver disease (NAFLD) than simple nonalcoholic ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). The interim results also reveal ...

Liver inflammation frequently occurs in connection with metabolic disorders, for example fatty liver disease. Lysomal acid lipase (LAL) deficiency is a rare metabolic disorder that also causes ...